Twenty-year changes in dementia occurrence suggest decreasing incidence in central Stockholm, Sweden
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received October 4, 2012
- Accepted in final form January 22, 2013
- First Published April 17, 2013.
Article Versions
- Previous version (April 17, 2013 - 13:01).
- You are viewing the most recent version of this article.
Author Disclosures
- Chengxuan Qiu, PhD,
- Eva von Strauss, PhD,
- Lars Bäckman, PhD,
- Bengt Winblad, MD, PhD and
- Laura Fratiglioni, MD, PhD
- Chengxuan Qiu, PhD,
NONE
NONE
NONE
Journal of Alzheimer Disease, Associated Editor, 2010- 2013.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
The Swedish Research Council, Project no. K2008-69X-20821-01-3, Years 2008-2012 and K2012-99X-21967-01-3, Years 2012-2015. (3) The Swedish Council for Working Life and Social Research, Grant No. 2007-1172, Years 2008-2012.
Karolinska Institutet, Stockholm, Sweden
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Eva von Strauss, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Lars Bäckman, PhD,
NONE
NONE
NONE
Aging, Neuropsychology, and Cognition
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Swedish Research Council Swedish Council for Working Life and Social Research Swedish Brain Power Alexander von Humboldt Foundation af Jochnick Foundation
NONE
NONE
NONE
NONE
NONE
NONE
- Bengt Winblad, MD, PhD and
Pharmaceutical companies having anti-dementia drugs.
NONE
Travel costs covered and receiving honoraria for scientific presentations at conferences and scientific advisory board meetings (SAB).
NONE
NONE
NONE
NONE
See above, SAB
NONE
NONE
NONE
NONE
Swedish Research Council (3 yrs). Knut&Alice Wallenberg foundation (5yrs).
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Laura Fratiglioni, MD, PhD
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- From Aging Research Center (C.Q., E.v.S., L.B., B.W., L.F.), Department of Neurobiology, Care Sciences and Society (NVS), Karolinska Institutet–Stockholm University; The Red Cross Hospital and the Red Cross University College in Sweden (E.v.S.); Stockholm Gerontology Research Center (L.B., L.F.); and KI-Alzheimer’s Disease Research Center (B.W.), Department of NVS, Karolinska Institutet, Stockholm, Sweden.
- Correspondence to Dr. Qiu: chengxuan.qiu{at}ki.se
Article usage
Cited By...
Disputes & Debates: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.